Living Health Technology Assessment: Issues, Challenges and Opportunities Praveen ThokalaTushar SrivastavaLesley Uttley Leading Article 18 January 2023 Pages: 227 - 237
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Antoinette D. I. van AsseltNigel ArmstrongSabine E. Grimm Review Article Open access 01 February 2023 Pages: 239 - 251
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review Marie-Hélène Blanchet ZumofenJeff FrimpterSvenn Alexander Hansen Systematic Review Open access 14 December 2022 Pages: 253 - 273
Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review Erik LandfeldtSophia AbnerJanbernd Kirschner Systematic Review 14 December 2022 Pages: 275 - 293
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment Yuqiong LuZhanjing DaiYun Lu Systematic Review Open access 19 January 2023 Pages: 295 - 306
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy Chen-Han ChuehYi-Wen TsaiNai-Jung Chiang Original Research Article 28 December 2022 Pages: 307 - 319
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? R. Brett McQueenKelly E. AndersonJosh J. Carlson Original Research Article 19 January 2023 Pages: 321 - 327
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned Sahar Al ShabasyBram RoudijkSamar Farid Original Research Article Open access 25 November 2022 Pages: 329 - 338
